About Mark Deem
Mark Deem is a director at Allay Therapeutics.
Form D filings also name Mark Deem as a director at Half Moon Medical, Nuvaira and Cala Health.
Mark Deem first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Deem in the role, so the role may have started earlier or lasted longer.
Nuvaira, Inc.
Director
2012 – 2018 · Minneapolis, MN
Develops a lung treatment device for people with chronic obstructive pulmonary disease.
Key Colleagues at Startups
The people Mark Deem works with at each company, as listed on that company's latest Form D.
Allay Therapeutics, Inc. · Form D, Feb 10, 2025
LR
Leighton Read
Director
NV
Nicole Vitullo
Director
MC
Michael Carusi
Director
TL
Tiffany Le
Director
AG
Adam Gridley
Chief Executive Officer and director
PM
Paul McCreadie
Director
JL
J.c. Lopez
Director
AT
Anselm Tan
Director
KH
Kristen Howells
Executive officer
Half Moon Medical, Inc. · Form D, Feb 22, 2023
MM
Matthew McLean
Chief Executive Officer and director
HI
Hanson Gifford III
Director
BI
Ben Brian III
Director
Nuvaira, Inc. · Form D, May 15, 2018
KN
Kirk Nielsen
Director
DS
Dave Stassen
Director
Dennis Wahr
President & CEO, director
HP
Hank Plain
Director
MC
Mike Carusi
Director
JW
James Lee Tze Wei
Director
Cala Health, Inc. · Form D, Feb 16, 2016
RP
Robert Paull
Director
KR
Kate Rosenbluth
Executive officer and director
TS
Terry Sanger
Executive officer
RR
Renee Ryan
Director
SD
Scott Delp
Director
MC
Michael Carusi
Director
SW
Serena Wong
Executive officer